8-K - Eton Pharmaceuticals, Inc. - 5.02 / 7.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001437749-26-012488

Filing Date: 2026-04-16

Accepted: 2026-04-16 07:05:15

Documents: 14

Period of Report: 2026-04-16

Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Eton Pharmaceuticals, Inc. (Filer) CIK : 0001710340 (see all company filings) EIN. : 371858472 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 26865652 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | FORM 8-K | eton20260413_8k.htm iXBRL | 8-K

2 | EXHIBIT 99.1 PRESS RELEASE RELATING TO CFO APPOINTMENT. | ex_945240.htm | EX-99.1

7 | etonlogo1.jpg | GRAPHIC | 5268

3 | XBRL TAXONOMY EXTENSION SCHEMA | eton-20260416.xsd | EX-101.SCH